Arzerra and Acetaminophen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arzerra (ofatumumab) and Acetaminophen (acetaminophen). Common drug interactions include feeling cold among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Arzerra and Acetaminophen. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Arzerra?

Arzerra has active ingredients of ofatumumab. eHealthMe is studying from 1,042 Arzerra users. Check the latest studies of Arzerra.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.



On Jul, 06, 2026

34 people who take Arzerra and Acetaminophen together, and have interactions are studied.

Arzerra and Acetaminophen drug interactions.

What are the common drug interactions of Arzerra and Acetaminophen, by gender? *:

female:

  1. Feeling cold
  2. Feeling hot
  3. Flushing (the warm, red condition of human skin)
  4. Gait disturbance
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Hypotension (abnormally low blood pressure)
  7. Loss of consciousness
  8. Nausea (feeling of having an urge to vomit)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pneumonia

male:

  1. Pruritus (severe itching of the skin)
  2. Abnormal behaviour
  3. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  4. Subdural haematoma (blood collects between the skull and the surface of the brain)
  5. Visual field defect
  6. White blood cell count decreased
  7. Inflammation
  8. Pneumonia
  9. Hypoxia (low oxygen in tissues)
  10. Infusion site extravasation (flow of (blood or lymph) from infusion site)

What are the common drug interactions of Arzerra and Acetaminophen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Arrhythmia (irregular heartbeat)
  2. Atrioventricular block second degree (heart block second degree)
  3. Blood calcium decreased
  4. Hypokalaemia (low potassium)
  5. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  6. Bradycardia (abnormally slow heart action)
  7. Electrocardiogram qt prolonged
  8. Heart rate decreased

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Inflammation
  2. Pruritus (severe itching of the skin)
  3. Fatigue (feeling of tiredness)
  4. Neuropathy peripheral (surface nerve damage)
  5. Oedema peripheral (superficial swelling)
  6. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  7. Bone pain
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Flushing (the warm, red condition of human skin)

60+:

  1. Pyrexia (fever)
  2. Abnormal behaviour
  3. Poverty of speech
  4. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  5. Subdural haematoma (blood collects between the skull and the surface of the brain)
  6. Visual field defect
  7. White blood cell count decreased
  8. Pneumonia
  9. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  10. Oxygen saturation decreased

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 22 people, 64.71%

* Approximation only. Some reports may have incomplete information.

Do you take Arzerra and Acetaminophen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arzerra and Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arzerra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arzerra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetaminophen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ofatumumab and acetaminophen (the active ingredients of Arzerra and Acetaminophen, respectively), and Arzerra and Acetaminophen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: